New biorepository aims to unlock secrets of lipedema
NCT ID NCT06180850
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study created a biorepository of blood and tissue samples from 60 women with and without lipedema. The goal was to find molecular markers that can distinguish lipedema from obesity, which is often misdiagnosed. Researchers measured immune markers and physical function tests to better understand the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better diagnostic tools for lipedema, helping distinguish it from obesity and enabling earlier management.
- What could go wrong
- This is an observational study that does not test a treatment, so it will not directly help patients. Results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Buoyancy vs. gravity: which exercise wins for lipedema relief?
- A simple step test could change how lipedema is assessed
- Can ultrasound reveal why lipedema makes walking hard?
- Can a new questionnaire better measure lipedema symptoms in turkish women?
- Ketogenic diet may offer pain relief for women with lipedema
- Shock waves aim to soothe lipedema pain in new trial